144 related articles for article (PubMed ID: 19590950)
1. The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.
Zhang H; Rakha EA; Ball GR; Spiteri I; Aleskandarany M; Paish EC; Powe DG; Macmillan RD; Caldas C; Ellis IO; Green AR
Breast Cancer Res Treat; 2010 May; 121(1):41-51. PubMed ID: 19590950
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer.
Alshareeda AT; Rakha EA; Nolan CC; Ellis IO; Green AR
Breast Cancer Res Treat; 2012 Jul; 134(2):519-29. PubMed ID: 22562177
[TBL] [Abstract][Full Text] [Related]
3. Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer.
Baker BG; Ball GR; Rakha EA; Nolan CC; Caldas C; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 Jan; 137(1):127-37. PubMed ID: 23208589
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of basal cytokeratin expression in breast cancer.
Alshareeda AT; Soria D; Garibaldi JM; Rakha E; Nolan C; Ellis IO; Green AR
Breast Cancer Res Treat; 2013 May; 139(1):23-37. PubMed ID: 23588953
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype.
Habashy HO; Powe DG; Rakha EA; Ball G; Macmillan RD; Green AR; Ellis IO
Breast Cancer Res Treat; 2010 Apr; 120(3):603-12. PubMed ID: 19495959
[TBL] [Abstract][Full Text] [Related]
6. A fatty acid-binding protein 7/RXRβ pathway enhances survival and proliferation in triple-negative breast cancer.
Liu RZ; Graham K; Glubrecht DD; Lai R; Mackey JR; Godbout R
J Pathol; 2012 Nov; 228(3):310-21. PubMed ID: 22322885
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of WWOX expression in patients with breast cancer and its association with the basal-like phenotype.
Wang X; Chao L; Ma G; Chen L; Zang Y; Sun J
J Cancer Res Clin Oncol; 2011 Feb; 137(2):271-8. PubMed ID: 20401669
[TBL] [Abstract][Full Text] [Related]
8. FABP7 expression in glioblastomas: relation to prognosis, invasion and EGFR status.
Kaloshi G; Mokhtari K; Carpentier C; Taillibert S; Lejeune J; Marie Y; Delattre JY; Godbout R; Sanson M
J Neurooncol; 2007 Sep; 84(3):245-8. PubMed ID: 17415524
[TBL] [Abstract][Full Text] [Related]
9. Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.
Rakha EA; El-Rehim DA; Paish C; Green AR; Lee AH; Robertson JF; Blamey RW; Macmillan D; Ellis IO
Eur J Cancer; 2006 Dec; 42(18):3149-56. PubMed ID: 17055256
[TBL] [Abstract][Full Text] [Related]
10. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
Liang Y; Bollen AW; Aldape KD; Gupta N
BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of fatty acid binding protein-7 correlates with basal-like subtype of breast cancer.
Tang XY; Umemura S; Tsukamoto H; Kumaki N; Tokuda Y; Osamura RY
Pathol Res Pract; 2010 Feb; 206(2):98-101. PubMed ID: 19608352
[TBL] [Abstract][Full Text] [Related]
12. Nestin expression in breast cancer: association with prognosis and subtype on 3641 cases with long-term follow-up.
Asleh K; Won JR; Gao D; Voduc KD; Nielsen TO
Breast Cancer Res Treat; 2018 Feb; 168(1):107-115. PubMed ID: 29159761
[TBL] [Abstract][Full Text] [Related]
13. Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients.
Tan DS; Marchió C; Jones RL; Savage K; Smith IE; Dowsett M; Reis-Filho JS
Breast Cancer Res Treat; 2008 Sep; 111(1):27-44. PubMed ID: 17922188
[TBL] [Abstract][Full Text] [Related]
14. Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study.
Powe DG; Voss MJ; Habashy HO; Zänker KS; Green AR; Ellis IO; Entschladen F
Breast Cancer Res Treat; 2011 Nov; 130(2):457-63. PubMed ID: 21298476
[TBL] [Abstract][Full Text] [Related]
15. FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast.
Gromov P; Espinoza JA; Talman ML; Honma N; Kroman N; Timmermans Wielenga V; Moreira JM; Gromova I
PLoS One; 2014; 9(11):e112024. PubMed ID: 25389781
[TBL] [Abstract][Full Text] [Related]
16. Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.
O Leary PC; Penny SA; Dolan RT; Kelly CM; Madden SF; Rexhepaj E; Brennan DJ; McCann AH; Pontén F; Uhlén M; Zagozdzon R; Duffy MJ; Kell MR; Jirström K; Gallagher WM
BMC Cancer; 2013 Apr; 13():175. PubMed ID: 23547718
[TBL] [Abstract][Full Text] [Related]
17. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
Rennstam K; McMichael N; Berglund P; Honeth G; Hegardt C; Rydén L; Luts L; Bendahl PO; Hedenfalk I
Breast Cancer Res Treat; 2010 Jul; 122(2):315-24. PubMed ID: 19795205
[TBL] [Abstract][Full Text] [Related]
18. DACH1: its role as a classifier of long term good prognosis in luminal breast cancer.
Powe DG; Dhondalay GK; Lemetre C; Allen T; Habashy HO; Ellis IO; Rees R; Ball GR
PLoS One; 2014; 9(1):e84428. PubMed ID: 24392136
[TBL] [Abstract][Full Text] [Related]
19. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.
Rakha EA; Putti TC; Abd El-Rehim DM; Paish C; Green AR; Powe DG; Lee AH; Robertson JF; Ellis IO
J Pathol; 2006 Mar; 208(4):495-506. PubMed ID: 16429394
[TBL] [Abstract][Full Text] [Related]
20. Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival.
Fulford LG; Reis-Filho JS; Ryder K; Jones C; Gillett CE; Hanby A; Easton D; Lakhani SR
Breast Cancer Res; 2007; 9(1):R4. PubMed ID: 17217540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
